Belite Bio, Inc Operating Income
Belite Bio, Inc (BLTE) reported Operating Income of -$84.21 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-03-31
| Period end | Operating Income (Loss) 12 month |
|---|---|
| 2025-12-31 | -$84.21M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$40.00M 20-F · filed 2026-03-31 |
| 2023-12-31 | -$31.67M 20-F · filed 2026-03-31 |
| 2022-12-31 | -$12.82M 20-F · filed 2025-03-17 |
| 2021-12-31 | -$9.80M 20-F · filed 2024-03-12 |
| 2020-12-31 | -$5.74M 20-F · filed 2023-03-31 |